Diabetes Devices And Drugs Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
Diabetes occurs when blood glucose, also called blood sugar, is too high. Insulin, a hormone made by the pancreas, helps glucose from food get into cells to be used for energy. There are various drugs and devices that help to monitor the blood glucose level. Devices such as Blood Glucose, meters and strips, continuous glucose monitors (CGMs), injection Pens for Insulin and GLP-1 Agonists, insulin pumps, and others are most commonly used.
MARKET DYNAMICS
Growing prevalence of diabetes with rising obesity rates, changing lifestyle and dietary habits, growing ageing population, and growing minimally invasive insulin delivery devices are the major drivers to propel the growth of this market.
MARKET SCOPE
The "Diabetes Devices and Drugs Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of diabetes devices and drugs market with detailed market segmentation by devices and drugs. The diabetes devices and drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in diabetes devices and drugs market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The diabetes devices and drugs market is segmented on the devices and drugs. Based on devices, the market is segmented as continuous blood glucose monitoring devices, test strips, self-monitoring devices, insulin delivery devices, and others. Based on drugs, the market is segmented as insulin, oral hypoglycaemic agents, and non-insulin injectable.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the diabetes devices and drugs market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The diabetes devices and drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting diabetes devices and drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the diabetes devices and drugs market in these regions.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the diabetes devices and drugs market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The diabetes devices and drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting diabetes devices and drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the diabetes devices and drugs market in these regions.
MARKET PLAYERS
The report covers key developments in the diabetes devices and drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from diabetes devices and drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for diabetes devices and drugs in the global market. Below mentioned is the list of few companies engaged in the diabetes devices and drugs market.
The report also includes the profiles of key players in diabetes devices and drugs market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- NOVO NORDISK A/S
- YPSOMED AG
- ABBOTT LABORATORIES
- ASCENSIA DIABETES CARE HOLDINGS AG
- ELI LILLY AND COMPANY
- HOFFMANN-LA ROCHE LTD
- JOHNSON AND JOHNSON
- MEDTRONIC PLC.
- BECTON, DICKINSON AND COMPANY
- TERUMO CORPORATION
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Diabetes Devices And Drugs Market - By Devices
1.3.2 Diabetes Devices And Drugs Market - By Drugs
1.3.3 Diabetes Devices And Drugs Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. DIABETES DEVICES AND DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. DIABETES DEVICES AND DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. DIABETES DEVICES AND DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. DIABETES DEVICES AND DRUGS - GLOBAL MARKET OVERVIEW
6.2. DIABETES DEVICES AND DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. DIABETES DEVICES AND DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - DEVICES
7.1. OVERVIEW
7.2. DEVICES MARKET FORECASTS AND ANALYSIS
7.3. CONTINUOUS BLOOD GLUCOSE MONITORING DEVICES
7.3.1. Overview
7.3.2. Continuous Blood Glucose Monitoring Devices Market Forecast and Analysis
7.4. TEST STRIPS
7.4.1. Overview
7.4.2. Test Strips Market Forecast and Analysis
7.5. SELF-MONITORING DEVICES
7.5.1. Overview
7.5.2. Self-monitoring Devices Market Forecast and Analysis
7.6. INSULIN DELIVERY DEVICES
7.6.1. Overview
7.6.2. Insulin Delivery Devices Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. DIABETES DEVICES AND DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - DRUGS
8.1. OVERVIEW
8.2. DRUGS MARKET FORECASTS AND ANALYSIS
8.3. INSULIN
8.3.1. Overview
8.3.2. Insulin Market Forecast and Analysis
8.4. ORAL HYPOGLYCAEMIC AGENTS
8.4.1. Overview
8.4.2. Oral Hypoglycaemic Agents Market Forecast and Analysis
8.5. AND NON-INSULIN INJECTABLE
8.5.1. Overview
8.5.2. and Non-Insulin Injectable Market Forecast and Analysis
9. DIABETES DEVICES AND DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Diabetes Devices And Drugs Market Overview
9.1.2 North America Diabetes Devices And Drugs Market Forecasts and Analysis
9.1.3 North America Diabetes Devices And Drugs Market Forecasts and Analysis - By Devices
9.1.4 North America Diabetes Devices And Drugs Market Forecasts and Analysis - By Drugs
9.1.5 North America Diabetes Devices And Drugs Market Forecasts and Analysis - By Countries
9.1.5.1 United States Diabetes Devices And Drugs Market
9.1.5.1.1 United States Diabetes Devices And Drugs Market by Devices
9.1.5.1.2 United States Diabetes Devices And Drugs Market by Drugs
9.1.5.2 Canada Diabetes Devices And Drugs Market
9.1.5.2.1 Canada Diabetes Devices And Drugs Market by Devices
9.1.5.2.2 Canada Diabetes Devices And Drugs Market by Drugs
9.1.5.3 Mexico Diabetes Devices And Drugs Market
9.1.5.3.1 Mexico Diabetes Devices And Drugs Market by Devices
9.1.5.3.2 Mexico Diabetes Devices And Drugs Market by Drugs
9.2. EUROPE
9.2.1 Europe Diabetes Devices And Drugs Market Overview
9.2.2 Europe Diabetes Devices And Drugs Market Forecasts and Analysis
9.2.3 Europe Diabetes Devices And Drugs Market Forecasts and Analysis - By Devices
9.2.4 Europe Diabetes Devices And Drugs Market Forecasts and Analysis - By Drugs
9.2.5 Europe Diabetes Devices And Drugs Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Diabetes Devices And Drugs Market
9.2.5.1.1 Germany Diabetes Devices And Drugs Market by Devices
9.2.5.1.2 Germany Diabetes Devices And Drugs Market by Drugs
9.2.5.2 France Diabetes Devices And Drugs Market
9.2.5.2.1 France Diabetes Devices And Drugs Market by Devices
9.2.5.2.2 France Diabetes Devices And Drugs Market by Drugs
9.2.5.3 Italy Diabetes Devices And Drugs Market
9.2.5.3.1 Italy Diabetes Devices And Drugs Market by Devices
9.2.5.3.2 Italy Diabetes Devices And Drugs Market by Drugs
9.2.5.4 Spain Diabetes Devices And Drugs Market
9.2.5.4.1 Spain Diabetes Devices And Drugs Market by Devices
9.2.5.4.2 Spain Diabetes Devices And Drugs Market by Drugs
9.2.5.5 United Kingdom Diabetes Devices And Drugs Market
9.2.5.5.1 United Kingdom Diabetes Devices And Drugs Market by Devices
9.2.5.5.2 United Kingdom Diabetes Devices And Drugs Market by Drugs
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Diabetes Devices And Drugs Market Overview
9.3.2 Asia-Pacific Diabetes Devices And Drugs Market Forecasts and Analysis
9.3.3 Asia-Pacific Diabetes Devices And Drugs Market Forecasts and Analysis - By Devices
9.3.4 Asia-Pacific Diabetes Devices And Drugs Market Forecasts and Analysis - By Drugs
9.3.5 Asia-Pacific Diabetes Devices And Drugs Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Diabetes Devices And Drugs Market
9.3.5.1.1 Australia Diabetes Devices And Drugs Market by Devices
9.3.5.1.2 Australia Diabetes Devices And Drugs Market by Drugs
9.3.5.2 China Diabetes Devices And Drugs Market
9.3.5.2.1 China Diabetes Devices And Drugs Market by Devices
9.3.5.2.2 China Diabetes Devices And Drugs Market by Drugs
9.3.5.3 India Diabetes Devices And Drugs Market
9.3.5.3.1 India Diabetes Devices And Drugs Market by Devices
9.3.5.3.2 India Diabetes Devices And Drugs Market by Drugs
9.3.5.4 Japan Diabetes Devices And Drugs Market
9.3.5.4.1 Japan Diabetes Devices And Drugs Market by Devices
9.3.5.4.2 Japan Diabetes Devices And Drugs Market by Drugs
9.3.5.5 South Korea Diabetes Devices And Drugs Market
9.3.5.5.1 South Korea Diabetes Devices And Drugs Market by Devices
9.3.5.5.2 South Korea Diabetes Devices And Drugs Market by Drugs
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Diabetes Devices And Drugs Market Overview
9.4.2 Middle East and Africa Diabetes Devices And Drugs Market Forecasts and Analysis
9.4.3 Middle East and Africa Diabetes Devices And Drugs Market Forecasts and Analysis - By Devices
9.4.4 Middle East and Africa Diabetes Devices And Drugs Market Forecasts and Analysis - By Drugs
9.4.5 Middle East and Africa Diabetes Devices And Drugs Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Diabetes Devices And Drugs Market
9.4.5.1.1 South Africa Diabetes Devices And Drugs Market by Devices
9.4.5.1.2 South Africa Diabetes Devices And Drugs Market by Drugs
9.4.5.2 Saudi Arabia Diabetes Devices And Drugs Market
9.4.5.2.1 Saudi Arabia Diabetes Devices And Drugs Market by Devices
9.4.5.2.2 Saudi Arabia Diabetes Devices And Drugs Market by Drugs
9.4.5.3 U.A.E Diabetes Devices And Drugs Market
9.4.5.3.1 U.A.E Diabetes Devices And Drugs Market by Devices
9.4.5.3.2 U.A.E Diabetes Devices And Drugs Market by Drugs
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Diabetes Devices And Drugs Market Overview
9.5.2 South and Central America Diabetes Devices And Drugs Market Forecasts and Analysis
9.5.3 South and Central America Diabetes Devices And Drugs Market Forecasts and Analysis - By Devices
9.5.4 South and Central America Diabetes Devices And Drugs Market Forecasts and Analysis - By Drugs
9.5.5 South and Central America Diabetes Devices And Drugs Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Diabetes Devices And Drugs Market
9.5.5.1.1 Brazil Diabetes Devices And Drugs Market by Devices
9.5.5.1.2 Brazil Diabetes Devices And Drugs Market by Drugs
9.5.5.2 Argentina Diabetes Devices And Drugs Market
9.5.5.2.1 Argentina Diabetes Devices And Drugs Market by Devices
9.5.5.2.2 Argentina Diabetes Devices And Drugs Market by Drugs
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL DIABETES DEVICES AND DRUGS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. DIABETES DEVICES AND DRUGS MARKET, KEY COMPANY PROFILES
12.1. NOVO NORDISK A/S
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. YPSOMED AG
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. , ABBOTT LABORATORIES
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ASCENSIA DIABETES CARE HOLDINGS AG
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ELI LILLY AND COMPANY
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. HOFFMANN-LA ROCHE LTD.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. JOHNSON AND JOHNSON
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. MEDTRONIC PLC
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. BECTON, DICKINSON AND COMPANY
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. TERUMO CORPORATION
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. NOVO NORDISK A/S
2. YPSOMED AG
3. ABBOTT LABORATORIES
4. ASCENSIA DIABETES CARE HOLDINGS AG
5. ELI LILLY AND COMPANY
6. HOFFMANN-LA ROCHE LTD
7. JOHNSON AND JOHNSON
8. MEDTRONIC PLC.
9. BECTON, DICKINSON AND COMPANY
10. TERUMO CORPORATION
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For